Biomarkers for stroke risk prediction in atrial fibrillation

29 August 2017 (15:12 - 15:30)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Jonas Oldgren

Uppsala University, Uppsala (Sweden)

4 More presentations in this session

Presentation thumbnail

State of the Art: stroke risk prediction in atrial fibrillation

Doctor I. Savelieva (London, GB)

Presentation thumbnail

Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc

Mr P. Nielsen (Aalborg, DK)

Abstract Slides Video

Presentation thumbnail

Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry

Doctor M. Proietti (Milan, IT)

Abstract Slides Video

Presentation thumbnail

A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials

Doctor Z. Hijazi (Uppsala, SE)

Access the full session

Session thumbnail

Stroke risk prediction in atrial fibrillation

The Event

ESC Congress 2017

29 August 2017 15:12 CET

You may be interested in

Webinar

ACVC Biomarker Talk Series - Biomarkers in atrial fibrillation

24 November 2021

Congress Presentation

Impaired heart rate variability triangular index predicts stroke and systemic embolism in patients with atrial fibrillation

3 April 2022

Congress Presentation

The interconnected pathophysiological pathways as inflammation, fibrosis and hypercoagulation are in pathogenesis of atrial fibrillation

31 March 2025

Congress Presentation

Myeloperoxidase as a biomarker for anticipating STEMI in individuals with atrial fibrillation.

13 May 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources